As the coronavirus spreads and infections with Covid-19 further increase throughout Europe, ECMO therapy turns out to be a necessary option for patients with severe courses. Xenios AG provides ECMO consoles that can be used for the treatment of patients who develop severe pneumonia and ARDS with lung failure which also might result from infection with the coronavirus.
A computational lung model can be used to reduce damage caused by mechanical ventilation – and could increase survival rates for patients significantly.
A technique that enables patients suffering from heart conditions to hold their breath safely for over 5 minutes could have potential as part of a new treatment for cardiac arrhythmias, say researchers at the University of Birmingham. In a new study, published in Frontiers in Physiology, researchers initially proposed the technique as a new means for earlier diagnosis of ischaemic heart disease.…
New research takes a novel approach to traditional, clinician-only sedative delivery, finding that select critically ill patients can safely self-administer sedatives to manage their anxiety during mechanical ventilation.
Lightweight, sturdy and simple to operate – the Oxylog VE300 is Dräger’s newly developed emergency and transport ventilator that is particularly apt for use outside of the hospital environment. Emergency doctors and paramedics can provide patients with the most important ventilation modes and, if necessary, use the device for CPR.
A study on weaning patients in intensive care units (ICUs) has compared those who underwent prolonged weaning off mechanical ventilation (MV) with patients classified as undergoing ‘simple’ or ‘difficult’ weaning. It shows that patients who experienced ‘prolonged’ weaning from mechanical ventilation show significantly higher mortality rates. Report: Mark Nicholls
A new study reveals that more than half of patients in intensive care units (ICU) using ventilators to help them breathe could benefit from assistive communication tools.
The new Carescape R860 is an intuitive critical care ventilator that uses advanced lung protection tools and an innovative user interface to help improve patient care.
Research being conducted in the United Kingdom is focusing on techniques to help improve the weaning process for patients coming off mechanical ventilation in hospital intensive care units. Report: Mark Nicholls
John Power is breathing easier after agreeing to let the Philips Home Healthcare deal with the complex and competitive consumer market for medical technology.
You’ll find Élie Azoulay everywhere during this year’s International Symposium on Intensive Care and Emergency Medicine (ISICEM).
Many physiological and observational studies indicate that non-invasive ventilation (NIV) after both thoracic and abdominal surgery is helpful and non-randomised trials have indeed confirmed the benefits.
To deliver the next step forward in mechanical ventilation, Jens Viebke, CEO of the Maquet-Getinge Group, decided to take a step backwards by first talking with the people who would be using the system.
While the benefits of extracorporeal membrane oxygenation (ECMO) as a temporary respiratory support for adult patients are still debated, it is undisputed that for many infants ECMO is the only chance to survive, because it provides them with time to strengthen their lungs
This May it will be exactly 60 years since the first extracorporeal circulation device to temporarily replace heart/ lung function was successfully used in a clinical setting.
There is little evidence on respiratory support with extracorporeal systems – enough of an argument for most of those doubting the procedure not to use it, or even make it available.
The use of endotracheal tubes with a dorsal lumen to allow drainage of respiratory secretions is currently not common in Germany, although two meta-analyses from the USA and Canada have already demonstrated that this special technique can reduce ventilator-associated pneumonia (VAP) by 45-50%.
Leveraging more than 100 years of anaesthesia expertise, GE Healthcare introduces ecoFLOW technology option to help guide clinicians in agent delivery, while providing economic and environmental benefits.
GE Healthcare yesterday announced the availability of the Giraffe® Stand-Alone Infant Resuscitation (STAR) System, which integrates critical capabilities to enhance effective resuscitation of newborns.
